Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now? — Neutral
JPME Zacks Investment Research — September 01, 2025Making its debut on 05/11/2016, smart beta exchange traded fund JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) provides investors broad exposure to the Style Box - Mid Cap Blend category of the market.
Should ProShares S&P 500 Ex-Technology ETF (SPXT) Be on Your Investing Radar? — Neutral
SPXT Zacks Investment Research — September 01, 2025Launched on September 22, 2015, the ProShares S&P 500 Ex-Technology ETF (SPXT) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
Should You Invest in the Vanguard Utilities ETF (VPU)? — Neutral
VPU Zacks Investment Research — September 01, 2025Looking for broad exposure to the Utilities - Broad segment of the equity market? You should consider the Vanguard Utilities ETF (VPU), a passively managed exchange traded fund launched on January 26, 2004.
Is Invesco S&P International Developed Quality ETF (IDHQ) a Strong ETF Right Now? — Positive
IDHQ Zacks Investment Research — September 01, 2025The Invesco S&P International Developed Quality ETF (IDHQ) made its debut on 06/13/2007, and is a smart beta exchange traded fund that provides broad exposure to the Foreign Large Growth ETF category of the market.
Analog Devices: Structural Compounding, Now In The Print Edition — Positive
ADI Seeking Alpha — September 01, 2025Analog Devices is entering a structural growth phase, driven by secular demand in AI, EVs, industrial automation, and precision healthcare. Q3 FY25 results showed revenue and margin beats, with bookings ahead of shipments, signaling sustainable, demand-driven growth across key verticals. Despite industry-leading margins and compounding potential, ADI trades at a discount to peers, presenting ~20% upside based on DCF and peer multiples.
Nvidia: Beating Estimates Isn't Enough For A $4 Trillion AI Company — Neutral
NVDA Seeking Alpha — September 01, 2025Nvidia beat Q2 expectations, but growth is slowing and the stock declined due to uncertainty around China H20 chip sales. Q2 revenue strength was driven by H20 shipments outside China, robust data center, gaming, and automotive segments, and strong margin performance. Q3 guidance is strong, with $54 billion in sales expected, but does not include potential upside from resumed China H20 shipments.
Coca-Cola® and Star Wars Unite to Celebrate Connection and the Uplifting Power of Fandom with New Campaign — Neutral
KO PRNewsWire — September 01, 2025Fans can collect 21 new character designs and unlock an immersive Augmented Reality (AR) experience to share powerful messages of community and connection ATLANTA , Sept. 1, 2025 /PRNewswire/ -- Coca-Cola® and Disney today announced a thrilling new collaboration to unite fans from across the galaxy, "Coca-Cola x Star Wars: Refresh Your Galaxy," celebrating the uplifting power of fandom and community.
Better Artificial Intelligence Stock: ASML vs. Taiwan Semiconductor — Positive
ASML TSM The Motley Fool — September 01, 2025The artificial intelligence (AI) boom has been fueled by large tech companies developing impressive AI models that can handle increasingly complex tasks. But a sometimes overlooked aspect of AI are the companies that manufacture complex processors that make those models possible.
ACM Research: Why This Chinese Chip Stock Is Just Getting Started — Positive
ACMR MarketBeat — September 01, 2025In the fast-paced world of investment trading, the market's first reaction is not always the final verdict. This was perfectly illustrated by ACM Research NASDAQ: ACMR in the month of August.
Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis — Neutral
PEG GlobeNewsWire — September 01, 2025Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis Copenhagen, September 01, 2025 Company Announcement No. 10 Reponex Pharmaceuticals A/S (Reponex), a subsidiary of Pharma Equity Group A/S (NASDAQ: PEG), today announced that it has received regulatory approval to initiate a pivotal Phase 2 clinical trial with its drug candidate RNX-011.
Before The Fed Blinks: 8% Yields That Wall Street Is Sleeping On — Positive
DEA MPLX Seeking Alpha — September 01, 2025Wall Street is ignoring two low-risk 8% yield machines hiding in plain sight. Rate cuts could send these income giants soaring. These opportunities may not last once the Fed makes its next move.
Iren Limited (IREN 14.97%) has emerged as one of the most explosive growth stories of 2025, with shares surging 221% over the past six months and 68% in just the last 30 days. The company's $7.2 billion market cap might seem stretched for a business primarily known for Bitcoin mining just a year ago.
BYD Stock Plummets. How China's EV Price War Tanked Tesla Rival's Earnings. — Negative
BYD Barrons — September 01, 2025The EV maker has been forced to offer steep discounts to defend its market share.
China taps global expertise to build world-class dinosaur geopark — Neutral
GPRK GlobeNewsWire — September 01, 2025YICHUN, China, Sept. 01, 2025 (GLOBE NEWSWIRE) -- On the sidelines of an international fossil protection forum in northeast China's Heilongjiang Province, hundreds of participants eagerly picked up hammers and carefully scoured the ground for fish fossils, immersing themselves in the hands-on thrill of excavation at the China National Geological Park of Dinosaurs.
TotalEnergies wins new offshore exploration permit in Congo Republic — Positive
TTE Reuters — September 01, 2025French oil major TotalEnergies has been awarded an exploration permit for the Nzombo area off the coast of the Republic of Congo, close to its already operational Moho facilities, it said on Monday.
Gold futures rise to record high on Fed concerns, rate cut expectations — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Market Watch — September 01, 2025Gold futures set a fresh record high on intensifying concerns around the U.S. Federal Reserve's independence, mounting interest-rate-cut bets and tariff uncertainty.
Domino's Pizza Group rises in London on buyback news — Positive
DPZ Proactive Investors — September 01, 2025Domino's Pizza Group PLC (LSE:DOM) shares climbed more than 8% in Monday morning's trade, after it announced a new £20 million share buyback programme. The buybacks will run until completion, and will reduce the firm's share capital.
NNN REIT: Quality Speaks For Itself, And The 3.4% Dividend Raise Amidst Tenant Risks Is Proof — Positive
NNN Seeking Alpha — September 01, 2025NNN REIT is attractively valued at a forward P/AFFO of 12.35x, offering solid upside if tenant headwinds are managed and rates decline. Q2 results showed year-over-year growth in revenue, core FFO, and AFFO, with management raising full-year guidance and increasing investment activity. The 3.4% dividend raise, now yielding 5.7%, is well covered by cash flows, reflecting strong portfolio quality and management confidence.
NEOG DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Neogen Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – NEOG — Neutral
NEOG GlobeNewsWire — September 01, 2025NEW YORK, Sept. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), of the important September 16, 2025 lead plaintiff deadline.
Rocket Lab (RKLB 1.42%) is one of the best-performing growth stocks over the past year. The stock is up 676% in the past 12 months as of this writing on Aug. 28, which actually bests the performance of Palantir Technologies, another hot stock over that time span.